Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Poster Icons
Spotlight Poster Icon
Spotlight Winner
Favorite
Like
Tweet
Print
John Penrod, PhD
Senior Director
Bristol Myers Squibb
Poster(s):
(87) Use of Immunosuppressive Drugs (ISD) and The Effectiveness of Immune Checkpoint Inhibitor (ICI) Therapy Among Patients with Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC) in the United States (US)
Saturday, August 27, 2022
8:00 AM - 6:00 PM
CEST
